Ivan Shishkin

Dr. Ivan Shishkin

Higher School of Medicine, Ualikhanov University, Kökshetaū, Aqmola, Kazakhstan
orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2024 in Asian Pacific Journal of Cancer Prevention
Verified
Journal Article
Open access
PDF file
NINurbek Igissin
Nurbek Igissin
SDSergey Dyakov
Sergey Dyakov
ZTZhansaya Telmanova
Zhansaya Telmanova
IKIndira Kudaibergenova
Indira Kudaibergenova
SASerik Ayaganov
Serik Ayaganov
ZBZarina Bilyalova
Zarina Bilyalova
Objective: The aim is to analyze the incidence of kidney cancer over a 15-year period, considering factors such as stage, age, sex, and morphological verification in the regional context in Kazakhstan. Methods: The retrospective study was done using descriptive and analytical methods of oncoepidemiology. The extensive, crude and age-specific incidence rates are determined according to the generally accepted methodology used in sanitary statistics. The data were used to calculate the average percentage change (APС) using the Joinpoint regression analysis to determine the trend over the study period. Results: Among the meticulously documented 15,277 cases, a conspicuous male predominance was noted, comprising 53.7% of cases compared to 46.3% in females, with peak incidences observed within the 50-69 age cohorts. The average age at diagnosis exhibited a progressive rise over the study period, with discernible variations observed in age-specific incidence rates, particularly pronounced within the 60-84 age brackets. Noteworthy temporal trends indicated a consistent uptick in crude incidence rates, with distinct regional disparities manifesting higher rates in northern regions relative to their southern and western counterparts. Stratification by cancer stage unveiled a significant surge in stages I-II cases alongside a concomitant decrement in stage III incidences, complemented by reductions in stage IV occurrences and instances of unspecified disease stages. Morphological verification rates displayed regional variations, with an overarching ascending trajectory across most regions, albeit exceptions noted, notably in the Kyzylorda region. Conclusion: Our study identified a rise in kidney cancer incidence in Kazakhstan, likely reflecting global trends driven by increased risk factor exposure and incidental imaging findings. Regional disparities and varied stage distributions highlight the complexity of kidney cancer epidemiology. Despite advancements in early detection, delayed diagnosis persists, necessitating improved surveillance and diagnostic practices.

1 May 2024 in Asian Pacific Journal of Cancer Prevention
Verified
Journal Article
Open access
PDF file
NINurbek Igissin
Nurbek Igissin
DODidar Orazbayev
Didar Orazbayev
ZTZhansaya Telmanova
Zhansaya Telmanova
IKIndira Kudaibergenova
Indira Kudaibergenova
NMNiyazbek Mamatov
Niyazbek Mamatov
KKKarina Kozhakhmet
Karina Kozhakhmet
Objective: The aim is to study the trends of liver cancer (LC) incidence in the regional context in Kazakhstan. Methods: The retrospective study was done using descriptive and analytical methods of oncoepidemiology. The extensive, crude and age-specific incidence rates are determined according to the generally accepted methodology used in sanitary statistics. The data were used to calculate the average percentage change (APС) using the Joinpoint regression analysis to determine the trend over the study period. Results: Between 2005 and 2019, 13,510 cases of LC were documented, comprising 59.3% males and 40.7% females. Most diagnoses were seen in age groups 55-59 years (13.3%) to 75-79 years (11.7%). LC patients’ average age increased from 63.6 to 64.5 years. Incidence rates per 100,000 peaked at ages 65-69 years (35.1±1.0) and 70-74 years (43.3±1.0). LC incidence notably rose in the 70-74 years age group (APC=+0.89), contrasting with declining trends in younger age groups. Regional incidence variations revealed diverse patterns, mostly demonstrating unimodal increases, and some regions displaying bimodal growth. The age-standardized incidence rate was 5.7±0.1 per 100,000, declining from 2005 to 2012 (APC: −3.93), then rising until 2019 (APC: +1.13). Gender-specific standardized rates showed varied trends. Analyses of standardized indicators indicated declining trends in most regions but increased values in specific areas. Thematic maps classified incidence rates based on standardized indicators: low (up to 5.22), average (5.22 to 7.11), high (above 7.11 per 100,000 for the entire population). Conclusion: The study on liver cancer in Kazakhstan reveals marked gender and age differences. The standardized incidence rate among men was twofold greater than that among women. A distinct rise in cases was noted among individuals aged 70-74 years. Regional variations in incidence were evident. These findings emphasize the necessity for focused research to comprehend the causes behind these differences, enabling customized interventions for Kazakhstan’s population.

31 March 2026 in Euroasian Health Journal
Verified
Journal Article
Closed access
NMN. Murzagulov
N. Murzagulov
ZTZ. Telmanova
Z. Telmanova
ISI. Shishkin
I. Shishkin
KRK. Rustemova
K. Rustemova
NIN. Igissin
N. Igissin
Diseases of the large intestine continue to make a significant contribution to population morbidity and mortality, which determines their high medical and social importance. Since the beginning of the 21st century, an increase in the prevalence of colorectal pathology has been observed, along with a shift in the age structure of patients toward younger groups, which highlights the relevance of analysing factors influencing the development of these diseases and approaches to their prevention. The aim of this review was to summarise and systematise current scientific evidence on risk determinants and strategies for reducing the burden of major diseases of the large intestine. An analysis of 52 publications was conducted, including systematic reviews, meta-analyses, large cohort studies, and randomised controlled trials retrieved from PubMed, Scopus, Web of Science, and Google Scholar databases. The review included studies published between 1990 and 2025, with 53.8% of the sources dated from 2020 to 2025. The literature analysis demonstrated that dietary patterns, excess body weight, low physical activity, smoking, and alcohol consumption play a leading role in the development of large intestinal diseases. Alterations in gut microbiota composition and chronic inflammation are considered key pathogenic mechanisms. A reduction in disease incidence and mortality has been confirmed for screening strategies based on endoscopic and noninvasive methods, as well as for selected pharmacological and technological approaches, including computerassisted endoscopic systems. The findings of this review may be applied in clinical practice, planning of screening programs, and development of prevention-oriented interventions within public health systems Заболевания толстого кишечника продолжают вносить значительный вклад в структуру заболеваемости и смертности населения, что обусловливает их высокую медико-социальную значимость. С начала XXI века отмечается рост распространённости колоректальной патологии, а также смещение возрастной структуры пациентов в сторону более молодых групп, что усиливает актуальность анализа факторов, влияющих на развитие данных заболеваний, и подходов к их предупреждению. Целью настоящей обзорной работы было обобщение и систематизация современных научных данных о детерминантах риска и мерах снижения бремени основных заболеваний толстого кишечника. Проведён анализ 52 публикаций, включающих систематические обзоры, метаанализы, крупные когортные и рандомизированные исследования, представленные в базах PubMed, Scopus, Web of Science и Google Scholar. В обзор включены работы, опубликованные в период с 1990 по 2025 годы, при этом 53,8% источников относятся к периоду 2020-2025 годов. Анализ литературы показал, что ведущую роль в формировании заболеваний толстого кишечника играют особенности питания, избыточная масса тела, низкий уровень физической активности, курение и злоупотребление алкоголем. Существенное значение имеют нарушения состава кишечной микробиоты и хроническое воспаление, рассматриваемые как ключевые патогенетические механизмы. Эффективность снижения заболеваемости и смертности подтверждена для скрининговых стратегий, основанных на эндоскопических и неинвазивных методах, а также для отдельных медикаментозных и технологических подходов, включая системы компьютерной поддержки эндоскопии. Результаты обзора могут быть использованы при клиническом ведении пациентов, планировании программ скрининга и разработке профилактически ориентированных мероприятий в системе общественного здравоохранения Жоон ичегинин оорулары калктын оорулуулугу жана өлүм-житими түзүмүндө олуттуу орунду ээлеп, алардын жогорку медициналык жана социалдык маанисин шарттайт. XXI кылымдын башынан тартып колоректалдык патологиянын таралышынын өсүшү, ошондой эле бейтаптардын жаш курактык түзүмүнүн жаш топтор тарапка жылышы байкалган. Бул жагдайлар аталган оорулардын өнүгүшүнө таасир этүүчү факторлорду жана алардын алдын алуу жолдорун талдоонун актуалдуулугун күчөткөн. Бул обзордук иштин максаты жоон ичегинин негизги...

30 June 2024 in Journal of Health Development
Verified
Journal Article
Open access
CKCademy Of Public Administration Under The President Of The Republic Of Kazakhstan
Cademy Of Public Administration Under The President Of The Republic Of Kazakhstan
NSNariman Syzdykov
Nariman Syzdykov
SASerik Ayaganov
Serik Ayaganov
KUKokshetau University named after Sh. Ualikhanov
Kokshetau University named after Sh. Ualikhanov
ZTZhansaya Telmanova
Zhansaya Telmanova
NINurbek Igissin
Nurbek Igissin
Зерттеудің мақсаты: Қазақстанның екі ірі мегаполисінде – Алматы және Астана қалаларында қуықасты безінің қатерлі ісігімен аурушаңдықтың ерекшеліктерін зерделеу.Әдістері. Зерттеу материалы Қазақстан Республикасы Денсаулық сақтау министрлігінің 2005-2019 жылдардағы қуықасты безінің қатерлі ісігіне (ICD 10 – C61) қатысты №7 жылдық нысаны болды. Негізгі әдіс ретінде медициналық-биологиялықстатистиканың дескриптивті және аналитикалық әдістерін қолдана отырып, ретроспективті зерттеу қолданылды.Нәтижесі. 2005-2019 жылдары Қазақстанда 14 740 жаңа қуықасты безінің қатерлі ісігі жағдайы тіркелді, оның ішінде 2296 (15,6%) және 625 (4,2%) науқас Алматы және Астана қалаларына тиесілі болды. Алматы қаласында науқастардың орташажасы 70,7±0,4 жасты және Астана қаласында 69,2±0,3 жасты құрады. Зерттелген мегаполистерде қуықасты безінің қатерлі ісігімен сырқаттанушылықтың стандартталған көрсеткіші: Алматы қаласында – 28,1±2,50/0000 (95% СА=23,3-32,9) (T=+5,1%) және Астана қаласында – 24,2±2,00/0000 (95% СА=20,3-28,2) (T=+2,1%). Айырмашылық статистикалық тұрғыдан маңызды болмады (t=1,22, р=0,223). Зерттелген мегаполистердегі аурушаңдықтың жас көрсеткіштерін талдау 70 және одан жоғары жас тобындағыөсуін көрсетті.Қорытынды. Біздің зерттеуіміздің нәтижелері қуықасты безінің қатерлі ісігімен күресте пәнаралық тәсілдерді одан әрі зерттеу және дамыту қажеттілігін көрсетеді. Бұл аурудың алдын алу және ерте анықтау тиімділігін арттыруға, сондай-ақ емдеу нәтижелері мен науқастардың өмір сүру сапасын жақсартуға көмектеседі

30 October 2025 in Journal of Health Development
Verified
Journal Article
Open access
НИН.с. Игісін
Н.с. Игісін
НЕН.е. Ермек
Н.е. Ермек
ИШИ.ю. Шишкин
И.ю. Шишкин
ЖТЖ.б. Тельманова
Ж.б. Тельманова
ГИГ.с. Игисинова
Г.с. Игисинова
ЗБЗ.а. Билялова
З.а. Билялова
The aim of this study is to assess the dynamics of prostate cancer incidence in Kazakhstan during the period 2005–2019 using component analysis methods. A retrospective epidemiological study was conducted based on data from the National Cancer Registry of Kazakhstan. Statistical methods included the calculation of age-standardized incidence rates, analysis of average annual growth rates, and component analysis of factors contributing to the increase in incidence. A total of 14,740 new prostate cancer cases were registered during the study period. The agestandardized incidence rate was 17.0 per 100.000 male population, showing an upward trend (T=+5.6%). The main factors contributing to the increase in incidence were changes in the age structure of the population (+10.9%), growthin the male population (+23.1%), and an increased risk of developing prostate cancer (+57.0%). The rising incidence of prostate cancer in Kazakhstan aligns with global trends and may be attributed to improved diagnostics, population aging, and changing risk factors. The findings can inform the development of prevention strategies, optimization of screening programs, and improvement of oncological care in the country.

30 October 2025 in Наука и здравоохранение
Verified
Journal Article
Open access
NIN.S. Igissin
N.S. Igissin
ZTZh.B. Telmanova
Zh.B. Telmanova
NMN.A. Murzagulov
N.A. Murzagulov
GIG.S. Igissinova
G.S. Igissinova
DTD.K. Turebaev
D.K. Turebaev
ZBZ.A. Bilyalova
Z.A. Bilyalova
Introduction. Rectal cancer constitutes a sizable share of the oncology workload. Reliable interpretation of long‑term trends requires disentangling demographic forces from genuine changes in age‑specific risk, particularly during program roll‑out and the service disruptions associated with COVID‑19. The aim of the study is to quantify the separate contributions of population size, age structure, and age‑specific risk to rectal cancer incidence in Kazakhstan, 2005–2024, partitioned into five phases: pre‑screening (2005–2010), early roll‑out (2011–2013), program stabilization (2014–2019), pandemic impact (2020–2021), and post‑pandemic recovery (2022–2024). Material and research methods. A population‑based retrospective study using the Ministry of Health Form No. 7 (ICD‑10: C19–C21). We applied a seven‑term decomposition with demographic components and risk‑related terms; here, “risk” denotes residual change in age‑specific incidence after removing demographic effects. Results. Over 2005–2024, 28,368 new cases were registered. The crude incidence rate (CR) increased from 7.80 to 9.13 per 100,000 (+1.34). Decomposition of CR yielded: ∑ΔA=+1.42, ∑ΔR=−0.05, ∑ΔRA=−0.03 (per 100,000), indicating a rise driven by population ageing with stable or slightly declining age-specific risks. By phase: 2005–2010 – declines in CR and ASR due to ΔR0); 2014–2019 – CR rises while ASR falls, increase fully demographic; 2020–2021 – compensatory increase versus 2020, yet 2021 below 2019; 2022–2024 – CR rises with a “flat” ASR, contribution almost exclusively demographic. Age profile stable: ages 50–79 ≈80.7% of registrations. Conclusions. The upward drift in crude incidence is primarily demographic, while true risk variation is phase‑bound and program‑linked. Policy should prioritize resilient early‑detection pathways, surge capacity for endoscopy, and routine component‑based surveillance focused on ages 50–79. Введение. Рак прямой кишки вносит существенный вклад в суммарную нагрузку онкологических заболеваний. Корректная интерпретация временных рядов требует раздельной оценки демографических эффектов и подлинной динамики возраст‑специфического риска, особенно при развёртывании организованного скрининга и структурных ограничениях периода COVID‑19. Цель исследования: количественно разложить вклад демографических факторов (численность населения и возрастная структура) и возраст‑специфического риска в изменение заболеваемости раком прямой кишки в Казахстане в 2005-2024 гг., с анализом пяти фаз: доскрининговый этап (2005-2010), раннее развёртывание (2011-2013), стабилизация программы (2014-2019), пандемическое воздействие (2020-2021) и постпандемическое восстановление (2022-2024). Материалы и методы. Популяционное ретроспективное исследование на основе официальной отчётной формы № 7 Минздрава РК (МКБ‑10: C19–C21). Для оценки динамики числа случаев применено компонентное разложение с выделением семи факторов. Результаты. За 2005–2024 гг. зарегистрировано 28 368 первичных случаев. Грубый показатель заболеваемости (ГП) вырос с 7,80 до 9,13 на 100 000 (+1,34). Декомпозиция ГП: суммарно ∑ΔA=+1,42, ∑ΔR=−0,05, ∑ΔRA=−0,03 (на 100 000) – прирост обусловлен старением населения при стабильных/слегка снижающихся возрастных рисках. По этапам: 2005–2010 – снижение ГП и ВСП за счёт ΔR0); 2014–2019 – рост ГП при снижении ВСП, прирост полностью демографический; 2020–2021 – компенсаторный рост относительно 2020 г., но уровень 2021 г. ниже 2019 г.; 2022–2024 – рост ГП при «плоском» ВСП, вклад почти исключительно демографический. Возрастной вклад устойчив: 50–79 лет ≈80,7% всех регистраций. Выводы. Долгосрочный рост заболеваемости определяется главным образом старением и увеличением численности населения; изменения «истинного» риска носят кратковременный характер и совпадают с программными и организационными сдвигами. Рекомендуется внедрять устойчивое компонентное наблюдение, планировать резерв мощности эндоскопии и фокусировать профилактику на когортах 50–79 лет. Кіріспе. Тік ішек қатерлі ісігі онкологиялық қызметтің елеулі бөлігін құрайды. Ұзақ мерзімді динамиканы дұрыс түсіндіру үшін демографиялық әсерлерді жас‑ерекшелік...